iPSC-Derived Cell Therapies Summit
Evvnt Promotion / evvnt
Archive
07.12.2021 - 09.12.2021 Virtual
Time: 9:00 am - 5:00 pm
Conference themes
Innovate The Next Generation of Safe, Scalable and Cost-Effective iPSC-Derived Therapies
The explosion of excitement and investment in the iPSC field has ushered in a new era of cell therapy, with these cells establishing it’s place as the optimal starting material for cell therapies targeting cancer, autoimmune, cardiac disease and much more.
Innovate The Next Generation of Safe, Scalable and Cost-Effective iPSC-Derived Therapies
The explosion of excitement and investment in the iPSC field has ushered in a new era of cell therapy, with these cells establishing it’s place as the optimal starting material for cell therapies targeting cancer, autoimmune, cardiac disease and much more.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/853667-3?pid=4832
Speakers: Helen Tayton-Martin, CBO, Adaptimmune, Jo Brewer, Head of Allogenic Research, Adaptimmune, Andres Bratt-Leal, Co-Founder, Aspen Neuroscience and more
Brochure: https://go.evvnt.com/853667-3?pid=4832
Speakers: Helen Tayton-Martin, CBO, Adaptimmune, Jo Brewer, Head of Allogenic Research, Adaptimmune, Andres Bratt-Leal, Co-Founder, Aspen Neuroscience and more
Enquiries and Registration:
https://go.evvnt.com/853667-1?pid=4832
Mr. Customer Services
Clinical Research, General Medicine
Languages
English
English
Congress fees
USD 1899.00 - USD 3597.00
USD 1899.00 - USD 3597.00
Participants expected
1000
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."